About Mithradote Bio
Mithradote Bio is a company based in San Diego (United States) founded in 2023 by Sophia Lee.. Mithradote Bio has raised $1 million across 1 funding round from investors including Taho Pharma and Vickers Venture Partners. Mithradote Bio offers products and services including M-101. Mithradote Bio operates in a competitive market with competitors including IgGenix, Tempero Bio, Globin Solutions, Sobrera and metaLead Therapeutics, among others.
- Headquarter San Diego, United States
- Founders Sophia Lee
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name Mithradote Bio, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1 M (USD)
in 1 rounds
-
Latest Funding Round
$1 M (USD), Seed
Oct 02, 2024
-
Investors
Taho Pharma
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Mithradote Bio
Mithradote Bio offers a comprehensive portfolio of products and services, including M-101. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Sublingual pan-antidote to reverse effects of benzodiazepines in drink spiking.
Funding Insights of Mithradote Bio
Mithradote Bio has successfully raised a total of $1M through 1 strategic funding round. The most recent funding activity was a Seed round of $1 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $1.0M
-
First Round
First Round
(02 Oct 2024)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2024 | Amount | Seed - Mithradote Bio | Valuation | Taho Pharma , Vickers Venture Partners |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Mithradote Bio
Mithradote Bio has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Taho Pharma and Vickers Venture Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Growth-stage venture capital is invested in Singapore and China.
|
Founded Year | Domain | Location | |
|
Company developing CNS and oncology drugs through their proprietary transepithelial drug delivery systems
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Mithradote Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Mithradote Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Mithradote Bio Comparisons
Competitors of Mithradote Bio
Mithradote Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as IgGenix, Tempero Bio, Globin Solutions, Sobrera and metaLead Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutic solutions for food allergies are developed via antibody platforms.
|
|
| domain | founded_year | HQ Location |
Therapeutics for substance use disorders, including opioid-related conditions, are developed.
|
|
| domain | founded_year | HQ Location |
Antidotal therapies for human poisonings are developed using neuroglobin technology.
|
|
| domain | founded_year | HQ Location |
Drugs for alcohol use disorders are developed by Sobrera.
|
|
| domain | founded_year | HQ Location |
Next-generation medications against metal poisoning are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Mithradote Bio
When was Mithradote Bio founded?
Mithradote Bio was founded in 2023 and raised its 1st funding round 1 year after it was founded.
Where is Mithradote Bio located?
Mithradote Bio is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Who is the current CEO of Mithradote Bio?
Sophia Lee is the current CEO of Mithradote Bio. They have also founded this company.
Is Mithradote Bio a funded company?
Mithradote Bio is a funded company, having raised a total of $1M across 1 funding round to date. The company's 1st funding round was a Seed of $1M, raised on Oct 02, 2024.
What does Mithradote Bio do?
Mithradote Bio was founded in 2023 and is based in San Diego, United States. Operations focus on the biotechnology sector, where medication is developed to counter drug-facilitated sexual assault. A lead product, M-101, is offered as a sublingual pan-antidote targeting benzodiazepines, Z drugs, and other GABA agonists. The company addresses preventive healthcare needs through targeted pharmaceutical solutions.
Who are the top competitors of Mithradote Bio?
Mithradote Bio's top competitors include IgGenix, Tempero Bio and Globin Solutions.
What products or services does Mithradote Bio offer?
Mithradote Bio offers M-101.
Who are Mithradote Bio's investors?
Mithradote Bio has 2 investors. Key investors include Taho Pharma, and Vickers Venture Partners.